Create amplicon panels with the genes you want. AmpliSeq for Illumina On Demand panels provide a choice of > 5000 pretested genes with known content relevant for inherited disease research, including hereditary cancer, primary immunodeficiency, hearing loss, and muscular dystrophy.
AmpliSeq chemistry and Illumina next-generation sequencing (NGS) technology provide unmatched data quality, even from low-quality starting materials such as formalin-fixed, paraffin-embedded (FFPE) tissues.
Choice of > 5000 pretested genes